drugset / Trial / NCT00566761
Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
RandomizedParallel-groupOpen-labelTreatment
Summary
Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-06
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 2.5 mg | Intravitreal |
| Subject | Triamcinolone | Other / unclassified | 4 mg | Intravitreal |